Back to Blog
Peptide Profiles••10 min read

Tirzepatide: The Dual Agonist Revolution in Weight Loss

Discover why Tirzepatide's dual mechanism is producing record-breaking weight loss results in clinical trials.

PeptIQ Research Team
Editorial
Tirzepatide: The Dual Agonist Revolution in Weight Loss
#tirzepatide#mounjaro#Zepbound#GLP-1#GIP#weight loss
Share this article

Track Your Peptide Protocols

Use PeptIQ to log injections, calculate doses, access our peptide library, and optimize your protocols.

Download PeptIQ